Serious Mental Illness, Other Mental Health Disorders, and Outpatient Health Care As Predictors of 30-day Readmissions Following Medical Hospitalization
Overview
Psychiatry
Authors
Affiliations
Objective: Prior research has not addressed whether both serious mental illness (SMI) and other mental health (OMH) disorders affect the likelihood of 30-day readmissions after medical hospitalizations, or whether post-discharge use of outpatient medical, mental health, and pharmacy services is associated with readmission likelihood.
Methods: Using the Truven Health Analytics MarketScan® Medicaid Multi-State Database, we studied 43,817 Medicaid beneficiaries, age 18-64, following discharge from medical hospitalizations in 2011. Logistic regression models compared all-cause, 30-day readmissions among those with SMI, OMH, and no psychiatric diagnosis, and examined associations of 30-day outpatient service use with 30-day readmissions.
Results: Thirty-day readmission rates were 15.9% (SMI), 13.8% (OMH), and 11.7% (no mental illness). In multivariable analysis, compared to patients without mental illness, odds of readmission were greater for those with SMI (aOR = 1.43, 95%CI:1.32-1.51) and OMH (aOR = 1.21, 95%CI:1.12-1.30), and lower among those using outpatient mental health services (aOR = 0.50, 95%CI: 0.44-0.56).
Conclusion: The adult Medicaid population disproportionately includes patients with SMI and OMH disorders, both of which were found to be associated with 30-day hospital readmissions. Receiving outpatient mental health services after hospital discharge may be protective against readmission following medical hospitalizations, suggesting the need for further research on these topics.
Brooks Carthon J, Tibbitt C, Amenyedor K, Bettencourt A, Babe E, Cacchione P Nurs Rep. 2024; 14(4):3803-3818.
PMID: 39728639 PMC: 11678105. DOI: 10.3390/nursrep14040278.
Brown D, Rosen C, Roberts S, Moneme A, Wirtalla C, Kelz R Ann Surg. 2024; 281(3):508-513.
PMID: 38639084 PMC: 11489320. DOI: 10.1097/SLA.0000000000006302.
Norman T, Guenther J, Vecerek N, Adler B, Crew A, Worswick S Skin Health Dis. 2023; 3(5):e266.
PMID: 37799370 PMC: 10549832. DOI: 10.1002/ski2.266.
Katschnig H, Strassmayr C, Endel F, Posch M, Steiner I Int J Methods Psychiatr Res. 2023; :e1983.
PMID: 37608583 PMC: 10804335. DOI: 10.1002/mpr.1983.